The Valley Desk

NCT03160521 · Interventional trial

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia

Overall registry status Completed

Phase 3

Conditions Acute Schizophrenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov